Štěpán Veselý

480 total citations
36 papers, 294 citations indexed

About

Štěpán Veselý is a scholar working on Pulmonary and Respiratory Medicine, Urology and Rheumatology. According to data from OpenAlex, Štěpán Veselý has authored 36 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 10 papers in Urology and 9 papers in Rheumatology. Recurrent topics in Štěpán Veselý's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (14 papers) and Urinary Bladder and Prostate Research (10 papers). Štěpán Veselý is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (14 papers) and Urinary Bladder and Prostate Research (10 papers). Štěpán Veselý collaborates with scholars based in Czechia, Sweden and Switzerland. Štěpán Veselý's co-authors include Tomas Knutson, Jan‐Erik Damber, Christer Dahlstrand, Mauro Dicuio, Pavel Dušek, Marko Babjuk, L. Jarolím, Richard Průša, J Závada and Zuzana Závadová and has published in prestigious journals such as Oncology Reports, Oncology and Tumor Biology.

In The Last Decade

Štěpán Veselý

30 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Štěpán Veselý Czechia 12 177 105 81 63 45 36 294
Jonathan Olivier France 12 369 2.1× 54 0.5× 111 1.4× 32 0.5× 29 0.6× 49 426
Eduardo I. Canto United States 10 336 1.9× 53 0.5× 112 1.4× 54 0.9× 39 0.9× 17 415
Kim Petterson Netherlands 4 390 2.2× 47 0.4× 153 1.9× 45 0.7× 22 0.5× 8 423
GRANT E. MEYER United States 7 306 1.7× 39 0.4× 104 1.3× 88 1.4× 44 1.0× 10 356
Hideki Mukouyama Japan 7 143 0.8× 52 0.5× 49 0.6× 134 2.1× 58 1.3× 15 288
Adriano Nesrallah Brazil 10 240 1.4× 94 0.9× 97 1.2× 177 2.8× 143 3.2× 37 471
Sameh Hijazi Germany 6 309 1.7× 30 0.3× 82 1.0× 23 0.4× 25 0.6× 16 364
Jonathan Ord United Kingdom 7 52 0.3× 85 0.8× 34 0.4× 84 1.3× 81 1.8× 8 270
Vahan Kassabian United States 6 501 2.8× 91 0.9× 156 1.9× 28 0.4× 65 1.4× 16 580
Martijn B. Busstra Netherlands 13 316 1.8× 35 0.3× 72 0.9× 78 1.2× 38 0.8× 32 493

Countries citing papers authored by Štěpán Veselý

Since Specialization
Citations

This map shows the geographic impact of Štěpán Veselý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Štěpán Veselý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Štěpán Veselý more than expected).

Fields of papers citing papers by Štěpán Veselý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Štěpán Veselý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Štěpán Veselý. The network helps show where Štěpán Veselý may publish in the future.

Co-authorship network of co-authors of Štěpán Veselý

This figure shows the co-authorship network connecting the top 25 collaborators of Štěpán Veselý. A scholar is included among the top collaborators of Štěpán Veselý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Štěpán Veselý. Štěpán Veselý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartolini, Robin, Lily Koumbas Foley, Dmitry Stakheev, et al.. (2024). Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma. Translational Oncology. 42. 101891–101891. 1 indexed citations
2.
Veselý, Štěpán, et al.. (2023). Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study. Anticancer Research. 43(4). 1675–1680. 4 indexed citations
3.
4.
5.
Veselý, Štěpán, et al.. (2020). Prevence recidivujících cystitid pomocí roztoku hyaluronátu sodného Flaveran. 24. 207–213. 2 indexed citations
6.
Čapoun, Otakar, et al.. (2020). The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy. World Journal of Urology. 39(6). 1889–1895. 13 indexed citations
7.
8.
Veselý, Štěpán, et al.. (2019). PSA a jeho izoformy jako moderní markery karcinomu prostaty. 23(3). 194–202. 1 indexed citations
9.
Střížová, Zuzana, Dmitry Stakheev, Simona Partlová, et al.. (2019). NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma. Urologic Oncology Seminars and Original Investigations. 37(7). 503–509. 17 indexed citations
10.
Veselý, Štěpán, Natalia Cernei, Ondřej Zítka, et al.. (2018). Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors. In Vivo. 32(2). 425–429. 6 indexed citations
11.
Čapoun, Otakar, et al.. (2017). The impact of prostate specific antigen density and prostate health index assessment for prediction of prostate cancer in prostate biopsy. European Urology Supplements. 16(11). e2872–e2872. 1 indexed citations
12.
Veselý, Štěpán, et al.. (2017). Engrailed 2 in urine fails as a marker in prostate cancer detection. European Urology Supplements. 16(10). e2646–e2646. 1 indexed citations
13.
Dušek, Pavel, Karel Kotaška, Štěpán Veselý, Richard Průša, & Marek Babjuk. (2016). Diagnostic Efficiency of Serum and Urine Procathepsin B and Cathepsin B in Patients with Carcinoma of the Urinary Bladder. Clinical Laboratory. 62(09/2016). 1709–1715. 1 indexed citations
14.
15.
Veselý, Štěpán, et al.. (2014). Prostate Specific Antigen. Current clinical application and future prospects. Biomedical Papers. 159(1). 18–26. 15 indexed citations
16.
Jarolím, L., Štěpán Veselý, Marek Babjuk, et al.. (2012). Časná salvage radioterapie po radikální prostatektomii indikovaná u pacientů s rostoucí hladinou PSA v hodnotách nižších, než je konvenční hranice biochemické recidivy 0,2 ng/ml. 16(2). 92–100.
17.
Veselý, Štěpán, et al.. (2012). Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome. World Journal of Urology. 31(2). 299–304. 14 indexed citations
18.
Dicuio, Mauro, et al.. (2010). Is it possible to predict post-residual voided urine by bladder scan before uroflowmetry--a useful and timesaving test to reduce the number of non--evaluable uroflow measurements?. PubMed. 82(2). 100–4. 1 indexed citations
19.
Dicuio, Mauro, Tomas Knutson, Štěpán Veselý, Jan‐Erik Damber, & Christer Dahlstrand. (2004). 30-MINUTES-TUMT. Urologia Internationalis. 73(2). 130–136. 2 indexed citations
20.
Veselý, Štěpán, Tomas Knutson, Magnus Fall, Jan‐Erik Damber, & Christer Dahlstrand. (2003). Clinical diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: Reliability of commonly measured parameters and the role of idiopathic detrusor overactivity. Neurourology and Urodynamics. 22(4). 301–305. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Olivier Breakdown of academic impact, for papers by Eduardo I. Canto Breakdown of academic impact, for papers by Kim Petterson Breakdown of academic impact, for papers by GRANT E. MEYER Breakdown of academic impact, for papers by Hideki Mukouyama Breakdown of academic impact, for papers by Adriano Nesrallah Breakdown of academic impact, for papers by Sameh Hijazi Breakdown of academic impact, for papers by Jonathan Ord Breakdown of academic impact, for papers by Vahan Kassabian Breakdown of academic impact, for papers by Martijn B. Busstra
Rankless by CCL
2026